Cue Biopharma, Inc

Call
Website
40 Guest St
Brighton, MA 02135
+1 (617) 949-2680
https://www.cuebiopharma.com

Cue Biopharma, Inc., based in Brighton, MA, is dedicated to mobilizing the patient's immune system to address serious diseases through innovative engineered biologics. Their approach focuses on selectively expanding and activating specific immune cells to restore immune balance by mimicking nature's signals.

The company is actively involved in developing next-generation treatments for autoimmune and inflammatory diseases, as evidenced by its recent partnerships and public offerings. With a strong commitment to advancing immunotherapy, Cue Biopharma is at the forefront of the biopharmaceutical industry's efforts to improve patient outcomes.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Blood derivatives

C4T Securities Corporation

C4 Therapeutics, Inc. is a biotechnology company based in Watertown, MA, specializing in targeted protein degradation. Their innovative approach, known as Targeted Protein Degradation (TPD), aims to develop a new generation of medicines for treating various diseases. Through their TORPEDO platform and focus on target selection, C4 Therapeutics is dedicated to transforming lives by degrading disease-causing proteins. With a strong leadership team, board of directors, and scientific advisory board, C4 Therapeutics is committed to advancing their pipeline of therapies, including CFT7455, CFT1946, and CFT8919. They also collaborate with industry partners such as Roche, Biogen, Betta Merck, and others to further their research and development efforts. At C4 Therapeutics, their values, people, and dedication to scientific progress drive their mission to revolutionize the treatment of diseases through targeted protein degradation.Generated from the website

Lyra Therapeutics Security Corporation

Lyra Therapeutics is a clinical-stage biotechnology company based in Watertown, MA, focused on developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). With a commitment to addressing the needs of the 14 million individuals in the United States suffering from this debilitating condition, Lyra aims to provide long-lasting treatment options that break the cycle of relentless medical management. The company's lead product candidate, LYR210, features a bioabsorbable nasal mesh designed to deliver continuous anti-inflammatory medication directly to the sinonasal tissues for up to six months. By integrating advanced materials science with proven medication, Lyra Therapeutics is poised to transform the treatment landscape for CRS patients, offering a new solution for an often overlooked community. Generated from the website

Bioentre, LLC

Bioentre, LLC is a biotechnology company based in Brookline, MA, specializing in research and development in the field of life sciences. With a focus on innovation and collaboration, Bioentre, LLC works towards advancing scientific discoveries and bringing cutting-edge technologies to market. Generated from their business information
United States›Massachusetts›Brighton›Cue Biopharma, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.